Development and Psychometric Evaluation of the Treatment-Emergent Activation and Suicidality Assessment Profile

Autor/inn/en	Reid, Jeannette M.; Storch, Eric A.; Murphy, Tanya K.; Bodzin, Danielle; Mutch, P. Jane; Lehmkuhl, Heather; Aman, Michael; Goodman, Wayne K.
Titel	Development and Psychometric Evaluation of the Treatment-Emergent Activation and Suicidality Assessment Profile
Quelle	In: Child & Youth Care Forum, 39 (2010) 2, S.113-124 (12 Seiten) PDF als Volltext Verfügbarkeit
Sprache	englisch
Dokumenttyp	gedruckt; online; Zeitschriftenaufsatz
ISSN	1053-1890
DOI	10.1007/s10566-010-9095-5
Schlagwörter	Clinical Diagnosis; Profiles; Psychometrics; Phenomenology; Suicide; Drug Therapy; Symptoms (Individual Disorders); Measures (Individuals); Youth; Behavior Disorders; Validity; Anxiety Disorders; Risk + Suchen Sie Ihr Suchwort? Charakterisierung; Profilanalyse; Psychometry; Psychometrie; Phenomenological psychology; Phänomenologie; Psychologie; Selbstmord; Psychiatrische Symptomatik; Messdaten; Jugend; Jugendlicher; Jugendalter; Gültigkeit; Risiko
Abstract	Although effective in treating a range of childhood psychiatric conditions, selective serotonin reuptake inhibitors (SSRI) have been implicated in the induction of an "activation syndrome" (characterized by symptoms of irritability, restlessness, emotional labiality, etc.) that may represent an intermediary state change that fosters suicidality. SSRI-induced activation syndrome is well-accepted by many clinicians and thought to be relatively common, particularly in children and teens. However, gaps exist in empirical data on phenomenology and tools for early detection. With this in mind, we report on a recently funded National Institutes of Health grant to develop a measure of behavioral activation to be completed in a clinical setting. We discuss the development of this measure--the Treatment-Emergent Activation and Suicidality Assessment Profile (TE-ASAP)--as well as psychometric results from a sample of youth with internalizing disorders who were at varying stages of SSRI treatment. Overall, psychometric data were quite promising, with the TE-ASAP demonstrating excellent reliability (i.e., internal consistency, inter-rater, short-term test-retest stability) and strong validity properties. Through further evaluation of the TE-ASAP in the context of a controlled multimodal trial in youth with obsessive-compulsive disorder, we hope to augment understanding of activation syndrome and, in turn, mitigate risks through early detection of this potentially life-threatening adverse effect. (As Provided).
Anmerkungen	Springer. 233 Spring Street, New York, NY 10013. Tel: 800-777-4643; Tel: 212-460-1500; Fax: 212-348-4505; e-mail: service-ny@springer.com; Web site: http://www.springerlink.com
Erfasst von	ERIC (Education Resources Information Center), Washington, DC
Update	2017/4/10